SCHEMBL22732893

SCHEMBL22732893

CNCC1CN(C2CCOCC2)CCO1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HTR4 Q13639 2/20 0.43
▸ HRH3 Q9Y5N1 11/20 0.41
▸ EPHA2 P29317 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ KCNH2 Q12809 2/20 0.32
▸ CCR2 P41597 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ PRKCG P05129 1/20 0.31
▸ PRKCB P05771 1/20 0.31
▸ PRKCA P17252 1/20 0.31
▸ PRKCH P24723 1/20 0.31
▸ PRKCE Q02156 1/20 0.31
▸ PRKCZ Q05513 1/20 0.31
▸ PRKCD Q05655 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22732597 0.85 HRH3 (0.34) HTR4HRH3
SCHEMBL23710207 0.85 HRH3 (0.34) HTR4HRH3
SCHEMBL22732724 0.83 HTR4 (0.45) HTR4HRH3EPHA2KDRKCNH2
SCHEMBL24171111 0.83 HTR4 (0.43) HTR4HRH3EPHA2KDRKCNH2
SCHEMBL24626968 0.83 HTR4 (0.43) HTR4HRH3EPHA2KDRKCNH2
SCHEMBL24170836 0.83 HTR4 (0.43) HTR4HRH3EPHA2KDRKCNH2
SCHEMBL23710030 0.81 HRH3 (0.47) HTR4HRH3EPHA2KDRKCNH2
SCHEMBL24627203 0.81 HTR4 (0.42) HTR4HRH3EPHA2KDR
SCHEMBL22732727 0.78 HRH3 (0.42) HTR4HRH3EPHA2KDRKCNH2
SCHEMBL22732611 0.78 HRH3 (0.42) HTR4HRH3EPHA2KDRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858832-A1 TRIFLUOROMETHYL-SUBSTITUTED SULFONAMIDE AS BCL-2-SELECTIVE INHIBITOR Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2021-08-04 — — EP disclosed
WO-2020238785-A1 METHYL- AND TRIFLUOROMETHYL-CONTAINING DISUBSTITUTED SULFONAMIDE SELECTIVE BCL-2 INHIBITOR 正大天晴药业集团股份有限公司 2020-12-03 — — WO disclosed
Send feedback